Author

Peter Zentis

University of CologneORCID 0000-0002-6999-132XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:imaging· 2 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Organism:human· 1

Frequent Co-Authors

Alexandra FloriniD· 1 shared Anna C. BeielsteiniD· 1 shared Anubhav PrakashiD· 1 shared Astrid C SchaussiD· 1 shared Carien M. NiesseniD· 1 shared Christian JüngstiD· 1 shared Christian Philipp PallaschiD· 1 shared Clémentine VilleneuveiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Alexandra FlorinORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologybioRxivPreprintApr 15, 2026

Tissue-scale mechanics controls differentiation strategy and dynamics of epithelial multilayering

Clémentine Villeneuve, Somiéalo Azote, Marga Albu…·Sara A. Wickström

The paper shows that tissue mechanics control epithelial multilayering by regulating cell differentiation and movement strategies in the developing mouse epidermis.

6 citations

mouseimaging

𝕏 PostBluesky

Cell BiologybioRxivPreprintSep 23, 2025

Focal adhesion pathway inhibition is the central axis of macrophage phenotypic responses to monoclonal antibody therapy in aggressive lymphoma via high-throughput screening and high-content imaging

Stuart James Blakemore, Peter Zentis, Linda Müller…·Christian Philipp Pallasch

This study identifies focal adhesion pathway inhibition as a key mechanism enhancing macrophage phagocytosis and improving anti-CD20 monoclonal antibody therapy in aggressive lymphoma through high-throughput screening and high-content imaging.

DOI 10.1101/2025.09.23.677924

humanflow cytometry

𝕏 PostBluesky